Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=amlnLatest Financial News for Amylin Pharmaceuticals, Inc.en-usThu, 7 Jan 2010 14:40:00 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/minyanville/rss/SIG=158gj582d/*http%3A//www.minyanville.com/articles/FDA-approval-drugs-tests-weight-loss-investors-stock-picks-2010-diabetes-multiple-sclerosis-minyanville/index/a/26249/from/yahooSignificant treatments seeking FDA approval this year and the stocks behind them.yahoo_finance/2764868487Thu, 7 Jan 2010 14:40:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13brt4mui/*http%3A//www.thestreet.com/_yahoo/story/10655693/1/analysts-name-top-biotech-stocks-for-2010-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2247581524Tue, 5 Jan 2010 13:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/100104/la31815.html?.v=1Amylin Pharmaceuticals, Inc. will be presenting at the J.P. Morgan Healthcare Conference in San Francisco on Monday, January 11, 2010 at 6:30 p.m. ET / 3:30 p.m. PT. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.yahoo_finance/1557593544Mon, 4 Jan 2010 21:15:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12latmv82/*http%3A//www.fool.com/investing/general/2009/12/31/2010-fda-decisions-to-watch.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2029017573Thu, 31 Dec 2009 19:23:56 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh32780_2009-12-30_14-05-20_lde5bt095_newsml&rpc=44&type=marketsNewsyahoo_finance/2521724697Wed, 30 Dec 2009 14:05:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://us.rd.yahoo.com/finance/editorial/xbizwk/SIG=12ecr1i9h/*http%3A//www.businessweek.com/investor/content/dec2009/pi20091224_131164.htm?campaign_id=yhooyahoo_finance/611769030Fri, 25 Dec 2009 13:09:07 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh83900_2009-12-23_23-08-19_n23169365_newsml&rpc=44&type=marketsNewsyahoo_finance/4035118461Wed, 23 Dec 2009 23:08:19 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=1222cj2mu/*http%3A//seekingalpha.com/article/179654-wednesday-options-recap?source=yahooyahoo_finance/3698783274Wed, 23 Dec 2009 21:02:10 Etc/GMThttp://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=12tcm0ia7/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/21/incyte-jumps-5-on-pact-with-lilly/?mod=yahoobarronsyahoo_finance/3046767644Mon, 21 Dec 2009 14:42:43 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12t1475gd/*http%3A//www.fool.com/investing/high-growth/2009/12/18/3-reasons-to-buy-dendreon-today.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/680562435Fri, 18 Dec 2009 19:34:01 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/minyanville/091217/20091217sharonhost_id.html?.v=2Maybe the experts know something we don't know.yahoo_finance/1870606820Thu, 17 Dec 2009 14:35:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=AMLNyahoo_finance/1480943625Thu, 17 Dec 2009 10:39:36 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091216/28397.html?.v=1Exenatide once weekly is currently being reviewed by the U.S. Food and Drug Administration ; a response should be out in the first quarter of 2010.yahoo_finance/3914593934Wed, 16 Dec 2009 21:54:59 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/amln8-k.htmlyahoo_finance/2464908690Tue, 15 Dec 2009 21:12:19 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh86309_2009-12-15_15-25-50_sge5be0j8_newsml&rpc=44&type=marketsNewsyahoo_finance/1274788825Tue, 15 Dec 2009 15:25:50 Etc/GMThttp://us.rd.yahoo.com/finance/external/cnbc/blog/rss/SIG=11h7vkhqe/*http%3A//www.cnbc.com/id/34428867/site/14081545?__source=yahoo%7Cheadline%7Cquote%7Ctext%7C&par=yahooyahoo_finance/3190692456Tue, 15 Dec 2009 14:24:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091215/la25979.html?.v=1Amylin Pharmaceuticals, Inc. , Eli Lilly and Company and Alkermes, Inc. today announced positive results from a head-to-head study comparing exenatide once weekly, an investigational diabetes therapy, to BYETTA® injection taken twice daily, in patients with type 2 diabetes.yahoo_finance/2914875578Tue, 15 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/xbarronsblog/rss/SIG=12i4bgq9r/*http%3A//blogs.barrons.com/stockstowatchtoday/2009/12/11/lly-caris-cuts-to-hold/?mod=yahoobarronsyahoo_finance/1580599533Fri, 11 Dec 2009 16:25:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12igf18ki/*http%3A//online.wsj.com/article/SB10001424052748704825504574586372262068060.html?ru=yahoo&mod=yahoo_hsyahoo_finance/4060445711Thu, 10 Dec 2009 04:06:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/091208/la22850.html?.v=1Amylin Pharmaceuticals, Inc. will be presenting at the Deutsche Bank Biotech Boston Confab on Tuesday, December 15, 2009 at 1:35 p.m. ET / 10:35 a.m. PT in Boston. Daniel M. Bradbury, president and chief executive officer of Amylin Pharmaceuticals, will provide a corporate overview.yahoo_finance/3133857411Tue, 8 Dec 2009 21:15:00 Etc/GMT